UY29207A1 - Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida - Google Patents
Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamidaInfo
- Publication number
- UY29207A1 UY29207A1 UY29207A UY29207A UY29207A1 UY 29207 A1 UY29207 A1 UY 29207A1 UY 29207 A UY29207 A UY 29207A UY 29207 A UY29207 A UY 29207A UY 29207 A1 UY29207 A1 UY 29207A1
- Authority
- UY
- Uruguay
- Prior art keywords
- phenyl
- acetamide
- hydroxy
- amino
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0425057A GB0425057D0 (en) | 2004-11-12 | 2004-11-12 | L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29207A1 true UY29207A1 (es) | 2006-06-30 |
Family
ID=33523659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29207A UY29207A1 (es) | 2004-11-12 | 2005-11-11 | Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida |
Country Status (8)
Country | Link |
---|---|
AR (1) | AR055282A1 (zh) |
GB (1) | GB0425057D0 (zh) |
GT (1) | GT200500328A (zh) |
NL (1) | NL1030405C2 (zh) |
PE (1) | PE20061131A1 (zh) |
TW (1) | TW200630324A (zh) |
UY (1) | UY29207A1 (zh) |
WO (1) | WO2006051375A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2320961B1 (es) * | 2007-11-28 | 2010-03-17 | Laboratorios Almirall, S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2. |
EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
EP2228368A1 (en) | 2009-03-12 | 2010-09-15 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
EP2578570A1 (en) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
WO2019071147A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2298511T3 (es) * | 2002-04-25 | 2008-05-16 | Glaxo Group Limited | Derivados de fenetanolamina. |
EP1460064A1 (en) * | 2003-03-14 | 2004-09-22 | Pfizer Limited | Indole-2-carboxamide derivatives useful as beta-2 agonists |
EP1577291A1 (en) * | 2004-03-17 | 2005-09-21 | Pfizer Limited | Phenylethanolamine derivatives as beta-2 agonists |
-
2004
- 2004-11-12 GB GB0425057A patent/GB0425057D0/en not_active Ceased
-
2005
- 2005-10-31 WO PCT/IB2005/003314 patent/WO2006051375A1/en active Application Filing
- 2005-11-10 PE PE2005001313A patent/PE20061131A1/es not_active Application Discontinuation
- 2005-11-11 TW TW094139768A patent/TW200630324A/zh unknown
- 2005-11-11 GT GT200500328A patent/GT200500328A/es unknown
- 2005-11-11 AR ARP050104741A patent/AR055282A1/es unknown
- 2005-11-11 UY UY29207A patent/UY29207A1/es not_active Application Discontinuation
- 2005-11-11 NL NL1030405A patent/NL1030405C2/nl not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB0425057D0 (en) | 2004-12-15 |
PE20061131A1 (es) | 2006-10-20 |
TW200630324A (en) | 2006-09-01 |
WO2006051375A1 (en) | 2006-05-18 |
AR055282A1 (es) | 2007-08-15 |
GT200500328A (es) | 2006-06-02 |
NL1030405C2 (nl) | 2006-12-12 |
NL1030405A1 (nl) | 2006-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29207A1 (es) | Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida | |
BRPI0719210A2 (pt) | Uso de compostos espiro-oxindol como agentes terapêuticos | |
EA200970140A1 (ru) | Производные и аналоги n-этилхинолонов и n-этилазахинолонов | |
CR10245A (es) | "nuevas combinaciones terapéuticas para el tratamiento de la depresión" | |
EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
ECSP23034537A (es) | Formulaciones farmaceuticas | |
BRPI0810863A2 (pt) | Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease. | |
BRPI0822033A2 (pt) | Composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, kit | |
GT200600316A (es) | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
DK1750683T3 (da) | Formuleringer med langvarig frigivelse | |
CY2013046I2 (el) | Καινοτομος χρηση των αντισωματων αντι il-1bhta | |
DE102006051625A8 (de) | Kombinationstherapie substituierter Oxazolidinone | |
ATE450243T1 (de) | Haarpflegezusammensetzung | |
BRPI0814034A2 (pt) | Uso de compostos à base de lantibiótico tipo-b com atividade antimicrobiana | |
UY30610A1 (es) | Moduladores de mglur5 | |
NI200900071A (es) | Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a. | |
DE602005026550D1 (de) | Hydrierten nitrilkautschuk enthaltende zusammensetzung | |
BRPI0815596A2 (pt) | Uso de compostos de sulfonanilida como herbicida | |
CR9144A (es) | Formulaciones de benzoxazoles sustituidos | |
BRPI0820941A2 (pt) | Uso de combinações de substâncias ativas para o combate de parasitas de animais. | |
BRPI0906978A2 (pt) | Composição, processos de preparação de uma composição e de um dispositivo combinado com medicamento, dispositivo combinado com medicamento, kit e uso de uma composição | |
NO20043305D0 (no) | Preparation of lodixanol | |
BRPI0913297A2 (pt) | composição, farmacêutica, uso de uma composição, e, kit terapêutico. | |
BRPI0815455A8 (pt) | compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição | |
PA8720601A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevenciòn de trastornos psicoticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160525 |